Clinical Trial Update: RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated everolimus (RAD001) in combination with CHOP chemotherapy for newly diagnosed peripheral T-cell lymphomas; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma Alk-negative
• Angioimmunoblastic T-cell Lymphoma
• Cutaneous T-cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Everolimus (everolimus)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative | Phase 1, Phase 2 | Status: COMPLETED